These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 30131850)

  • 1. N
    Fry NJ; Law BA; Ilkayeva OR; Carraway KR; Holley CL; Mansfield KD
    Oncotarget; 2018 Jul; 9(58):31231-31243. PubMed ID: 30131850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of N6-methyladenosine modulators promote breast cancer progression.
    Wu L; Wu D; Ning J; Liu W; Zhang D
    BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Radioactivity-Based Assay for Screening Human m6A-RNA Methyltransferase, METTL3-METTL14 Complex, and Demethylase ALKBH5.
    Li F; Kennedy S; Hajian T; Gibson E; Seitova A; Xu C; Arrowsmith CH; Vedadi M
    J Biomol Screen; 2016 Mar; 21(3):290-7. PubMed ID: 26701100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m6A regulates breast cancer proliferation and migration through stage-dependent changes in Epithelial to Mesenchymal Transition gene expression.
    Dorgham MG; Elliott BA; Holley CL; Mansfield KD
    Front Oncol; 2023; 13():1268977. PubMed ID: 38023205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis.
    Yu H; Yang X; Tang J; Si S; Zhou Z; Lu J; Han J; Yuan B; Wu Q; Lu Q; Yang H
    Mol Ther Nucleic Acids; 2021 Mar; 23():27-41. PubMed ID: 33376625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Expression of
    Shi Y; Zheng C; Jin Y; Bao B; Wang D; Hou K; Feng J; Tang S; Qu X; Liu Y; Che X; Teng Y
    Front Oncol; 2020; 10():1126. PubMed ID: 32766145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALKBH5 promotes cadmium-induced transformation of human bronchial epithelial cells by regulating PTEN expression in an m6A-dependent manner.
    Li L; Zhou M; Chen B; Wang Q; Pan S; Hou Y; Xia J; Zhou X
    Ecotoxicol Environ Saf; 2021 Aug; 224():112686. PubMed ID: 34438274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.
    Cheng Y; Fu Y; Wang Y; Wang J
    Front Genet; 2020; 11():955. PubMed ID: 33061938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3-Mediated N6-Methyladenosine Modification Is Involved in the Dysregulation of NRIP1 Expression in Down Syndrome.
    Shi W; Yang F; Dai R; Sun Y; Chu Y; Liao S; Hao B
    Front Cell Dev Biol; 2021; 9():621374. PubMed ID: 33869171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.
    Yuan Y; Du Y; Wang L; Liu X
    J Cancer; 2020; 11(12):3588-3595. PubMed ID: 32284755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m6A Methyltransferase 3 Promotes the Proliferation and Migration of Gastric Cancer Cells through the m6A Modification of YAP1.
    Zhou W; Xian Q; Wang Q; Wu C; Yan H; Li X; Lu L; Wu C; Zhu D; Xu X; Wu J
    J Oncol; 2021; 2021():8875424. PubMed ID: 34394353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of methyltransferase-like enzyme 3 and methyltransferase-like enzyme 14 in urological cancers.
    Tao Z; Zhao Y; Chen X
    PeerJ; 2020; 8():e9589. PubMed ID: 32765970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression.
    Xiang S; Liang X; Yin S; Liu J; Xiang Z
    Am J Transl Res; 2020; 12(5):1789-1806. PubMed ID: 32509177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of m6A methyltransferase METTL3 in gastric cancer cells results in suppression of cell proliferation.
    Jiang L; Chen T; Xiong L; Xu JH; Gong AY; Dai B; Wu G; Zhu K; Lu E; Mathy NW; Chen XM
    Oncol Lett; 2020 Sep; 20(3):2191-2198. PubMed ID: 32782536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3 suppresses neuropathic pain via modulating N6-methyladenosine-dependent primary miR-150 processing.
    Zhang L; Zhao X; Wang J; Jin Y; Gong M; Ye Y; Li P
    Cell Death Discov; 2022 Feb; 8(1):80. PubMed ID: 35210391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation.
    Mu X; Zhao Q; Chen W; Zhao Y; Yan Q; Peng R; Zhu J; Yang C; Lan K; Gu X; Wang Y
    Front Oncol; 2020; 10():526866. PubMed ID: 33489865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases.
    Zhang B; Jiang H; Dong Z; Sun A; Ge J
    Genes Dis; 2021 Nov; 8(6):746-758. PubMed ID: 34522705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner.
    Wang W; Huang Q; Liao Z; Zhang H; Liu Y; Liu F; Chen X; Zhang B; Chen Y; Zhu P
    Exp Hematol Oncol; 2023 Jan; 12(1):1. PubMed ID: 36609413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.
    Xie J; Ba J; Zhang M; Wan Y; Jin Z; Yao Y
    J BUON; 2021; 26(2):444-449. PubMed ID: 34076991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.